News from Anthera Pharmaceuticals, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 17, 2012, 15:00 ET Anthera Pharmaceuticals to Present at the BioCentury Future Leaders Conference

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...


Mar 15, 2012, 17:00 ET Anthera Provides Corporate Update on Recent Activities

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


Mar 09, 2012, 17:00 ET Anthera Halts VISTA-16 Clinical Study Due to Lack of Efficacy Following Recommendation by the Independent Data Safety Monitoring Board

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


Mar 05, 2012, 17:00 ET Dr. Bogdan Dziurzynski Joins Anthera Pharmaceuticals Board of Directors

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and...


Mar 05, 2012, 08:00 ET Anthera Pharmaceuticals Completes Interim Analysis of PEARL-SC Clinical Trial with Blisibimod

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases including cardiovascular and...


Feb 23, 2012, 17:00 ET Anthera Pharmaceuticals to Present at the Citi Global Health Care Conference

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


Feb 21, 2012, 08:00 ET Anthera Pharmaceuticals Reports 2011 Fourth Quarter Financial Results and Provides Clinical Progress Update

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended December 31, 2011....


Feb 09, 2012, 17:00 ET Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call

 Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with...


Dec 14, 2011, 17:00 ET Anthera Announces Completion of Safety Review by DSMB for VISTA-16

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation...


Dec 05, 2011, 17:00 ET Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing therapeutics to treat serious diseases associated with...


Dec 01, 2011, 08:00 ET Anthera Pharmaceuticals Completes Interim B-Cell Analysis of PEARL-SC Study

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


Nov 01, 2011, 16:15 ET Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended September 30, 2011....


Oct 25, 2011, 16:30 ET Anthera Announces Last Patient Enrolled in PEARL-SC Study

Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


Oct 24, 2011, 21:00 ET Anthera Announces Third Quarter 2011 Financial Report and Conference Call

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


Sep 08, 2011, 16:39 ET Anthera Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering A-002 Plus Statin Compositions

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation,...


Jul 29, 2011, 08:00 ET Anthera Pharmaceuticals Reports 2011 Second Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2011....


Jun 08, 2011, 16:00 ET Anthera Pharmaceuticals Announces Completion of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public offering of...


Jun 03, 2011, 09:00 ET Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 6,666,667 shares of its common...


Jun 02, 2011, 16:00 ET Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it intends to offer and sell shares of its common stock in an underwritten...


May 03, 2011, 17:00 ET Anthera Pharmaceuticals Reports 2011 First Quarter Financial Results and Operational Update

Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced financial results and business highlights for the quarter ended March 31, 2011....